Big news from Chinas new crown vaccine! Prepare for mass production

category:Finance
 Big news from Chinas new crown vaccine! Prepare for mass production


Sun Chunlan pointed out that at present, 14 vaccines from 5 technical routes have entered clinical trials, among which 5 vaccines are conducting phase III clinical trials according to the procedures and standards, and the work of emergency use and production preparation has been promoted orderly.

Sun Chunlan pointed out that in the next step, we should continue to scientifically and rigorously promote the phase III clinical trials of vaccines, and do a good job in the review and approval work in strict accordance with laws and regulations and internationally recognized technical standards, so as to ensure that the vaccine is safe and effective and can withstand all aspects of testing. We should be ready for mass production.

It is necessary to study and formulate the vaccination distribution plan after the marketing of vaccines, clarify the population scope, vaccination sequence and time considerations, and organize personnel training in disease control institutions and grass-roots vaccination units in advance. According to the needs of winter epidemic prevention and control, this year, we will complete the emergency use of high-risk groups such as relevant employees and front-line supervisors at the port. Vaccines are closely related to peoples life safety. All relevant departments should strictly enforce the management system of vaccine research and development, production, circulation and use, strengthen the construction of approval, issuance and supervision capacity, help research and development units and production enterprises solve practical problems, carry out publicity and education on vaccine knowledge, so as to enable people to have a scientific and rational understanding of vaccines and actively do a good job in vaccination and personal protection.

Turkish medical expert: Chinese vaccine can provide enough protection

Recently, corona VAC, a new crown vaccine developed by China Kexing biological Co., Ltd., has officially entered the third phase of clinical trial in Ankara, Turkey, according to the international online. Many Turkish medical experts and netizens have given affirmation and trust to Chinese vaccines.

In an interview with CNN Turkey, Professor Tufan tukek, Dean of the chiapa School of medicine at Istanbul University, said that there had been no serious adverse reactions in Chinese vaccine clinical trials conducted by countries around the world.

Interview with CNN Turkey

In an interview with Turkish NTV TV station, member of Turkeys Scientific Committee against new crown disease, tavifek ozlu, said that at present, there is no obvious rejection and discomfort among people vaccinated in China. So far, more than 1700 medical staff have been vaccinated in China, and no adverse reactions have occurred.

According to reports, the preliminary test results of the third phase clinical trial showed that although the antibody produced by the kelifor vaccine was less than that detected in the body of the new crown rehabilitation patients, it could rapidly induce immune response. Based on past experience, the researchers said, it is judged that kelifor can provide adequate protection.

According to Beijing Satellite TV, Turkey has begun to count asymptomatic infections and will buy 50 million doses of Chinas Kexing vaccine.

The international clinical trial of a Chinese enterprises new crown vaccine is being successfully carried out in 10 countries, including the United Arab Emirates, Bahrain, Egypt, Jordan, Peru, Argentina and Morocco. More than 56000 volunteers have been vaccinated, covering 125 nationalities. In the clinical trials, some of the volunteers were political leaders from various countries, such as the crown prince and Prime Minister of the kingdom of Bahrain Salman, and the Minister of health and population of Egypt, khaley, who participated in the trial. On September 14 and November 3, the United Arab Emirates and Bahrain announced that they would use the new crown vaccine of a certain enterprise for emergency use in their own countries. The UAE emergency vaccination personnel included its vice president and Prime Minister al Maktoum.

Dont underestimate the challenges, which require collaboration between different supply chains

However, the success of vaccine research and development is only the first step in the long march. There are still many challenges for a single dose of vaccine, from the laboratory to the final human vaccination. Even if the problems of R & D and mass production are solved, the problems of upstream and downstream industrial chain, which are closely related to it, can not be ignored.

In addition, according to Chuancai securities, international analysts pointed out that the current epidemic situation is still very serious, the new death toll in Europe is on the rise, and the sharp rise in the hospitalization rate of covid-19 in Europe has led to the re implementation of blockade in many European countries. In addition, the United States has reported record hospitalization rates, the rapid growth of cases and the rise in the number of deaths has broken through the previous top. Although it is still some time before the large-scale production and application of the vaccine, the positive development of the new crown vaccine has enhanced the expectation of the future economy. Even if the re emergence of the virus and re strict restrictions seem to disrupt economic activities in the short term, the economic recovery will accelerate again in 2021, and the cumulative activity loss caused by the virus impact will ultimately be the global financial crisis (GFC) uff09A little bit after that. Source: daily economic news from international online, Xinhua news agency, Beijing Satellite TV, CCTV finance and economics, national medicine group, etc. source: Daily Economic News Editor: Wang Xiaowu_ NF

In addition, according to Chuancai securities, international analysts pointed out that the current epidemic situation is still very serious, the new death toll in Europe is on the rise, and the sharp rise in the hospitalization rate of covid-19 in Europe has led to the re implementation of blockade in many European countries. In addition, the United States has reported record hospitalization rates, the rapid growth of cases and the rise in the number of deaths has broken through the previous top. Although it is still some time before the large-scale production and application of the vaccine, the positive development of the new crown vaccine has enhanced the expectation of the future economy. Even if the re emergence of the virus and re strict restrictions seem to disrupt economic activities in the short term, the economic recovery will accelerate again in 2021, and the cumulative activity loss caused by the virus impact will ultimately be the global financial crisis (GFC) uff09A little bit after that.

vaccines